← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2019Last known activity
May 1, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 4 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT04940338Study directorPhase 4May 1, 2021
- NCT04940338Lead sponsorPhase 4May 1, 2021
- NCT04940338Reponsible party - principal investigatorPhase 4May 1, 2021
- NCT04940338Overall official - principal investigatorPhase 4May 1, 2021
- NCT04891588Lead sponsorN/AMar 8, 2021
- NCT04891588Overall official - principal investigatorN/AMar 8, 2021
- NCT04456777Lead sponsorEarly Phase 1Jul 1, 2020
- NCT03841474Reponsible party - principal investigatorN/AMar 1, 2019
- NCT03841474Lead sponsorN/AMar 1, 2019
Details
- Last known activity
- May 1, 2021